Benzonatate Dose Tolerance Study

NCT01690975 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

9

Enrollment

INDUSTRY

Sponsor class

Conditions

Cough

Interventions

DRUG: Placebo
DRUG: Benzonatate - 400 mg
DRUG: Benzonatate - 600 mg

Sponsor

Pfizer